Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$180M |
| 2 |
BHI
Baker Hughes
BHI
|
+$173M |
| 3 |
Dominion Energy
D
|
+$161M |
| 4 |
Kinder Morgan
KMI
|
+$155M |
| 5 |
Marathon Petroleum
MPC
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$177M |
| 2 |
SLB Ltd
SLB
|
+$121M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$119M |
| 4 |
PepsiCo
PEP
|
+$110M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 13.03% |
| 2 | Healthcare | 11.97% |
| 3 | Financials | 8.32% |
| 4 | Utilities | 7.31% |
| 5 | Consumer Discretionary | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGNT
1126
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $6.44M | 0.02% |
206,963
-198,836
| -49% | -$5.39M |
|
1127
PUT
lululemon athletica
LULU
$13.5B
| $6.44M | 0.02% |
153,200
+27,900
| +22% | +$1.12M |
|
1128
Greif
GEF
$4.92B
| $6.43M | 0.02% |
146,812
+137,203
| +1,428% | +$6.85M |
|
1129
Vanda Pharmaceuticals
VNDA
$307M
| $6.43M | 0.02% |
619,579
+359,372
| +138% | +$4.71M |
|
|
RXDX
1130
DELISTED
Ignyta, Inc.
RXDX
| $6.42M | 0.02% |
796,870
-45,542
| -5% | -$366K |
|
1131
KBR
KBR
$4.62B
| $6.42M | 0.02% |
+341,014
| New | +$7.4M |
|
1132
Constellation Brands
STZ
$22.2B
| $6.42M | 0.02% |
73,639
-63,356
| -46% | -$5.51M |
|
|
WIN
1133
DELISTED
Windstream Holdings Inc
WIN
| $6.42M | 0.02% |
+75,977
| New | +$6.51M |
|
|
NBSE
1134
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $6.41M | 0.02% |
2,212
-408
| -16% | -$1.35M |
|
1135
Melco Resorts & Entertainment
MLCO
$2.22B
| $6.4M | 0.02% |
243,383
+111,369
| +84% | +$3.36M |
|
1136
iShares Russell 1000 Value ETF
IWD
$82.2B
| $6.39M | 0.02% |
+63,800
| New | +$6.46M |
|
1137
A.O. Smith
AOS
$8.17B
| $6.36M | 0.02% |
269,164
-55,890
| -17% | -$1.36M |
|
1138
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $6.36M | 0.02% |
32,281
-84,415
| -72% | -$16.7M |
|
1139
Strategy Inc
MSTR
$34.1B
| $6.36M | 0.02% |
485,920
+275,780
| +131% | +$3.84M |
|
1140
Coty
COTY
$2.42B
| $6.34M | 0.02% |
382,875
-416,727
| -52% | -$7.27M |
|
1141
Sensata Technologies
ST
$6.74B
| $6.3M | 0.02% |
141,560
-159,033
| -53% | -$7.54M |
|
1142
AtriCure
ATRC
$1.92B
| $6.3M | 0.02% |
427,759
+9,597
| +2% | +$153K |
|
|
ATRS
1143
DELISTED
Antares Pharma, Inc.
ATRS
| $6.3M | 0.02% |
3,440,975
-626,506
| -15% | -$1.37M |
|
|
PCL
1144
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
| $6.29M | 0.02% |
161,353
+133,559
| +481% | +$5.57M |
|
|
OSG
1145
Octave Specialty Group
OSG
$243M
| $6.29M | 0.02% |
284,690
-90,889
| -24% | -$2.14M |
|
1146
iShares Core S&P 500 ETF
IVV
$878B
| $6.29M | 0.02% |
31,728
+23,767
| +299% | +$4.73M |
|
1147
Charles River Laboratories
CRL
$11.2B
| $6.28M | 0.02% |
105,143
-79,954
| -43% | -$4.57M |
|
|
AFSI
1148
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $6.26M | 0.02% |
314,470
+114,414
| +57% | +$2.42M |
|
|
SMA
1149
DELISTED
SYMMETRY MEDICAL INC
SMA
| $6.25M | 0.02% |
619,544
+489,135
| +375% | +$4.53M |
|
|
SLXP
1150
CALL
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $6.25M | 0.02% |
40,000
+2,800
| +8% | +$406K |
|
Similar funds
Millennium Management's Q3 2014 Portfolio in Review
As of Q3 2014, Millennium Management held 4,400 positions worth $39.5B, up 9.5% from $36.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Millennium Management deployed $4.94B of net new capital in Q3 2014, opening 1,066 new positions and adding to 1,336 existing holdings. Its largest new stake was St Jude Medical: 1,407,737 shares worth $84.6M.
By sector, the portfolio is most concentrated in Energy at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was SLB Ltd, an estimated $121M trimmed.
- Millennium Management's largest Q3 2014 buy was St Jude Medical: 1,407,737 shares worth $84.6M.
- Millennium Management added most to Marathon Oil Corporation in Q3 2014, an estimated $180M increase.
- Millennium Management's biggest Q3 2014 reduction was SLB Ltd, cutting an estimated $121M.
- Millennium Management fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $177M.
- Millennium Management's ten largest holdings make up 11% of its $39.5B portfolio in Q3 2014.
- Millennium Management opened 1,066 new positions and closed 749 in Q3 2014.
- Millennium Management's portfolio value rose 9.5% quarter-over-quarter to $39.5B.
Based on Millennium Management's 13F filing for Q3 2014, filed 14 Nov 2014.